Education
About Us
Working with TipRanks
Follow Us
Bafna Pharmaceuticals Limited (IN:BAFNAPH)
:BAFNAPH
BAFNAPH Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹67.80 - ₹94.90
Previous CloseN/A
Volume2.58K
Average Volume (3M)1.25K
Market Cap
₹1.99B
Enterprise Value₹2.35B
Total Cash (Recent Filing)₹13.15M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)50.3
Beta0.40
Next Earnings
Aug 08, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 19, 2013Dividend YieldN/A
Share Statistics
EPS (TTM)0.55
Shares Outstanding23,656,336
10 Day Avg. Volume2,379
30 Day Avg. Volume1,252
Financial Highlights & Ratios
PEG Ratio-13.12
Price to Book (P/B)2.47
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Bafna Pharmaceuticals Limited News
PremiumCompany Announcements
Bafna Pharmaceuticals Completes Sale of Chennai Manufacturing Unit
PremiumCompany Announcements
Bafna Pharmaceuticals Submits Annual SEBI Disclosure
PremiumCompany Announcements
Bafna Pharmaceuticals Announces Board and Committee Restructuring
PremiumCompany Announcements
Bafna Pharmaceuticals Announces Board and Committee RestructuringBAFNAPH FAQ
What was Bafna Pharmaceuticals Limited’s price range in the past 12 months?
Bafna Pharmaceuticals Limited lowest stock price was ₹67.80 and its highest was ₹94.90 in the past 12 months.
What is Bafna Pharmaceuticals Limited’s market cap?
Bafna Pharmaceuticals Limited’s market cap is ₹1.99B.
When is Bafna Pharmaceuticals Limited’s upcoming earnings report date?
Bafna Pharmaceuticals Limited’s upcoming earnings report date is Aug 08, 2025 which is in 22 days.
How were Bafna Pharmaceuticals Limited’s earnings last quarter?
Currently, no data Available
Is Bafna Pharmaceuticals Limited overvalued?
According to Wall Street analysts Bafna Pharmaceuticals Limited’s price is currently Overvalued.
Does Bafna Pharmaceuticals Limited pay dividends?
Bafna Pharmaceuticals Limited pays a Notavailable dividend of ₹0.6 which represents an annual dividend yield of N/A. See more information on Bafna Pharmaceuticals Limited dividends here
What is Bafna Pharmaceuticals Limited’s EPS estimate?
Bafna Pharmaceuticals Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bafna Pharmaceuticals Limited have?
Bafna Pharmaceuticals Limited has 23,656,336 shares outstanding.
What happened to Bafna Pharmaceuticals Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bafna Pharmaceuticals Limited?
Currently, no hedge funds are holding shares in IN:BAFNAPH
Company Description
Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited (BAFNAPH) is an Indian pharmaceutical company engaged in the development, manufacturing, and marketing of pharmaceutical formulations. The company operates in the pharmaceutical sector, focusing primarily on niche therapeutic areas and generic drug manufacturing. Bafna Pharmaceuticals serves both domestic and international markets, offering a wide range of products that include tablets, capsules, and liquid formulations to meet various healthcare needs.
Technical Analysis
Aarey Drugs & Pharmaceuticals Ltd.
―
Alpa Laboratories Limited
―
Bal Pharma Limited
―
Krebs Biochemicals & Industries Ltd.
―
Mangalam Drugs & Organics Ltd.
―